Anthony Cusano, MD
Nephrology · Waterbury, CTNPI 1205944089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $785 and has fallen 96.6% since, to $26 in 2025.
Across 158 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$508
- Novo Nordisk$438
- Boehringer Ingelheim$310
- Mallinckrodt Hospital Products Inc.$265
- Otsuka America Pharmaceutical, Inc.$193
- Amgen$185
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,18793%
- Education$2427%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 22 | $508 |
| Novo Nordisk | 32 | $438 |
| Boehringer Ingelheim | 9 | $310 |
| Mallinckrodt Hospital Products Inc. | 8 | $265 |
| Otsuka America Pharmaceutical, Inc. | 10 | $193 |
| Amgen(2 entities) | 9 | $185 |
| Akebia Therapeutics Inc | 8 | $172 |
| Vifor Pharma, Inc. | 7 | $171 |
| Sanofi | 8 | $165 |
| Medtronic | 1 | $129 |
| Travere Therapeutics, Inc. | 7 | $120 |
| Baxter Healthcare | 5 | $103 |
| Bayer | 4 | $91 |
| Ultragenyx Pharmaceutical Inc. | 5 | $90 |
| OPKO Pharmaceuticals, LLC | 3 | $77 |
| Fresenius USA Marketing, Inc. | 4 | $64 |
| Smith+Nephew | 1 | $58 |
| GSK | 3 | $57 |
| AMAG Pharmaceuticals, Inc. | 3 | $54 |
| Aurinia Pharma U.S., Inc. | 2 | $51 |
| Calliditas Therapeutics US Inc. | 2 | $33 |
| Nxstage Medical, Inc. | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MazorX - Renaissance$129
- JARDIANCE$125
- FARXIGA$125
How this compares
$3,429 in reported general payments places this provider in the 75th percentile of 144 nephrology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Allopurinol | 27 | $1,936 |
| Amlodipine Besylate | 119 | $687 |
| Losartan Potassium | 59 | $614 |
| Rosuvastatin Calcium | 49 | $595 |
| Spironolactone | 37 | $504 |
| Tamsulosin Hcl | 28 | $494 |
| Chlorthalidone | 26 | $386 |
| Levothyroxine Sodium | 42 | $380 |
| Lisinopril | 45 | $328 |
| Metoprolol Succinate | 23 | $276 |
| Atorvastatin Calcium | 38 | $275 |
| Furosemide | 24 | $217 |
| Metformin Hcl | 19 | $215 |
| Carvedilol | 19 | $190 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 11 | $172 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Waterbury
- Marc CiampiWaterbury$16K
- Sandeep TiyyaguraWaterbury$5K
- Andrew DonatiWaterbury$4K
- Robert AlpernNew Haven$4.9M
- Ari GellerBloomfield$209K
- Richard FormicaNew Haven$198K
- Stefan SomloNew Haven$111K
- James GavinTrumbull$103K
- Fredric FinkelsteinNew Haven$70K
- Justin BelcherNew Haven$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.